{"created":"2023-06-20T15:49:25.948112+00:00","id":4024,"links":{},"metadata":{"_buckets":{"deposit":"dc6114ad-1a1c-4b3e-82a7-67a1aa46877c"},"_deposit":{"created_by":4,"id":"4024","owners":[4],"pid":{"revision_id":0,"type":"depid","value":"4024"},"status":"published"},"_oai":{"id":"oai:hama-med.repo.nii.ac.jp:00004024","sets":["1:11"]},"author_link":["12431"],"item_3_alternative_title_1":{"attribute_name":"その他のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"特集：前立腺癌診療 update ー最新の診断と治療ー　III.診断と治療"}]},"item_3_biblio_info_5":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2020-06-01","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"6","bibliographicPageEnd":"1018","bibliographicPageStart":"1012","bibliographicVolumeNumber":"78","bibliographic_titles":[{"bibliographic_title":"日本臨牀 = Japanese Journal of Clinical Medicine"}]}]},"item_3_description_10":{"attribute_name":"注記","attribute_value_mlt":[{"subitem_description":"通巻1177号","subitem_description_type":"Other"}]},"item_3_description_9":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Of two approved taxanes against metastatic castration-resistant prostate cancer (mCRPC), docetaxel was a first agent demonstrated to improve the prognosis of chemotherapy-na?ve mCRPC patients, while cabazitaxel was shown to prolong survival of docetaxel-refractory mCRPC patients. Despite various newly available options for mCRPC patients, these two taxanes have continued to play potential roles in the sequential therapy for mCRPC patients; that is, it has been currently regarded as the most preferable strategy against mCRPC to introduce docetaxel followed  by cabazitaxel after the failure of novel androgen receptor-axis-targeted agent. In this review, we attempted to summarize the clinical significance of taxanes in sequential treatment for mCRPC patients based on established evidence as well as our experience in routine clinical practice.","subitem_description_type":"Abstract"}]},"item_3_publisher_6":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"日本臨牀社"}]},"item_3_relation_27":{"attribute_name":"医中誌論文ID","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"2020278610","subitem_relation_type_select":"ICHUSHI"}}]},"item_3_rights_7":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"出版者の許諾を得て掲載"},{"subitem_rights":"★出版者の方針により印刷不可"}]},"item_3_source_id_19":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0047-1852","subitem_source_identifier_type":"ISSN"}]},"item_3_version_type_32":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"三宅, 秀明"}],"nameIdentifiers":[{"nameIdentifier":"12431","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2022-05-12"}],"displaytype":"detail","filename":"日本臨牀-78-1012.pdf","filesize":[{"value":"2.6 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"日本臨牀-78-1012.pdf","url":"https://hama-med.repo.nii.ac.jp/record/4024/files/日本臨牀-78-1012.pdf"},"version_id":"dbf9a66b-2600-45ad-b481-d6d1d501cb04"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"docetaxel","subitem_subject_scheme":"Other"},{"subitem_subject":"cabazitaxel","subitem_subject_scheme":"Other"},{"subitem_subject":"sequential therapy","subitem_subject_scheme":"Other"},{"subitem_subject":"mCRPC","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"mCRPCに対する逐次治療におけるタキサン系抗がん薬の役割","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"mCRPCに対する逐次治療におけるタキサン系抗がん薬の役割","subitem_title_language":"ja"},{"subitem_title":"Role of taxanes during sequential therapy for patients with mCRPC","subitem_title_language":"en"}]},"item_type_id":"3","owner":"4","path":["11"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2022-05-09"},"publish_date":"2022-05-09","publish_status":"0","recid":"4024","relation_version_is_last":true,"title":["mCRPCに対する逐次治療におけるタキサン系抗がん薬の役割"],"weko_creator_id":"4","weko_shared_id":-1},"updated":"2023-08-02T07:36:06.843836+00:00"}